MD official logo MD
MD 2-star rating from Upturn Advisory
Mednax Inc (MD) company logo

Mednax Inc (MD)

Mednax Inc (MD) 2-star rating from Upturn Advisory
$22.34
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/09/2026: MD (2-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 2 star rating for performance

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Number of Analysts

2 star rating from financial analysts

8 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $22.67

1 Year Target Price $22.67

Analysts Price Target For last 52 week
$22.67 Target price
52w Low $11.84
Current$22.34
52w High $24.99

Analysis of Past Performance

Type Stock
Historic Profit 36.61%
Avg. Invested days 44
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 01/09/2026

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.94B USD
Price to earnings Ratio 11.64
1Y Target Price 22.67
Price to earnings Ratio 11.64
1Y Target Price 22.67
Volume (30-day avg) 8
Beta 0.74
52 Weeks Range 11.84 - 24.99
Updated Date 01/9/2026
52 Weeks Range 11.84 - 24.99
Updated Date 01/9/2026
Dividends yield (FY) -
Basic EPS (TTM) 1.91

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 8.44%
Operating Margin (TTM) 15.02%

Management Effectiveness

Return on Assets (TTM) 6.86%
Return on Equity (TTM) 19.98%

Valuation

Trailing PE 11.64
Forward PE 9.17
Enterprise Value 2062457074
Price to Sales(TTM) 1.01
Enterprise Value 2062457074
Price to Sales(TTM) 1.01
Enterprise Value to Revenue 1.07
Enterprise Value to EBITDA 7.81
Shares Outstanding 85877386
Shares Floating 83073297
Shares Outstanding 85877386
Shares Floating 83073297
Percent Insiders 2.13
Percent Institutions 98.83

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Mednax Inc

Mednax Inc(MD) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Mednax, Inc. was founded in 1983 as Pediatrix Medical Group by Dr. Roger H. Medel. It initially focused on providing neonatal intensive care physician services. Over the years, the company expanded its service offerings and geographic reach through organic growth and strategic acquisitions, evolving into a national healthcare company specializing in physician services. Significant milestones include its initial public offering (IPO) in 1993, expansion into various pediatric subspecialties, and the rebranding to Mednax, Inc. in 2017 to reflect its broader diversification beyond pediatrics.

Company business area logo Core Business Areas

  • Pediatric and Neonatal Services: This segment is the historical core of Mednax, providing physician services for neonatology, pediatric critical care, pediatric hospitalists, and other pediatric subspecialties. These services are typically delivered in hospital settings.
  • Anesthesia Services: Mednax offers a wide range of anesthesia services to hospitals and health systems, covering various surgical specialties, pain management, and women's health.
  • Radiology Services: The company provides radiology physician services, including diagnostic imaging and interventional radiology, to hospitals and outpatient imaging centers.
  • Other Physician Services: This includes a range of other specialized physician services such as emergency medicine, maternal-fetal medicine, and other critical care specialties.

leadership logo Leadership and Structure

Mednax, Inc. is led by a Board of Directors and a senior executive management team. As of recent reports, its leadership includes a CEO, CFO, and various division presidents overseeing its different service lines. The company operates through a decentralized model with numerous physician groups contracted to provide services within affiliated hospitals and health systems across the United States.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Neonatal Intensive Care Unit (NICU) Physician Services: Mednax is a leading provider of neonatologists and neonatal critical care physicians to NICUs nationwide. While specific market share figures for this niche are proprietary, Mednax is recognized as a dominant player. Competitors include other large physician staffing companies and independent hospital-based groups.
  • Pediatric Hospitalist Services: The company supplies pediatric hospitalists to manage the care of hospitalized children. This is a significant service line with broad demand. Competitors include hospitals' in-house physician groups and other national staffing firms.
  • Anesthesia Services: Mednax provides comprehensive anesthesia staffing and management to surgical centers and hospitals. The anesthesia services market is competitive, with numerous national and regional providers.
  • Radiology Services: The company offers radiology physician coverage and management. This segment competes with national radiology groups and independent practices.

Market Dynamics

industry overview logo Industry Overview

Mednax operates within the healthcare services sector, specifically focusing on physician practice management and outsourced medical services. The industry is characterized by an aging population, increasing demand for specialized care, and a growing trend of hospitals outsourcing physician services to manage costs and ensure quality. Regulatory changes, reimbursement policies, and consolidation within the hospital and payer landscape significantly impact this sector.

Positioning

Mednax is positioned as a large, diversified provider of physician services, particularly strong in neonatology and pediatrics. Its competitive advantages include its established national network of affiliated physician groups, long-standing relationships with hospitals, operational expertise in managing physician practices, and its ability to offer a broad spectrum of services. However, it faces intense competition and pressures related to reimbursement rates and physician recruitment.

Total Addressable Market (TAM)

The Total Addressable Market for outsourced physician services in the US is substantial and growing, driven by hospital needs for efficiency and specialized care. While precise TAM figures for Mednax's specific niches are difficult to isolate, the broader physician staffing and management market is estimated to be in the tens of billions of dollars. Mednax aims to capture a significant portion of this by offering comprehensive and specialized services to hospitals and health systems across the country.

Upturn SWOT Analysis

Strengths

  • Extensive national network of affiliated physician practices.
  • Long-standing relationships with hospitals and health systems.
  • Diversified service lines across multiple specialties.
  • Strong historical presence and expertise in neonatology and pediatrics.
  • Operational efficiency and economies of scale.

Weaknesses

  • Dependence on hospital contracts, which can be subject to renegotiation or termination.
  • Vulnerability to reimbursement rate changes from government and private payers.
  • Challenges in physician recruitment and retention in certain specialties.
  • Potential for increased competition from smaller, specialized groups or hospital consolidation.
  • Integration risks with past and future acquisitions.

Opportunities

  • Expansion into new geographic markets and service lines.
  • Leveraging technology for telehealth and remote patient monitoring.
  • Partnerships with health systems to manage physician groups more strategically.
  • Growth in demand for specialized pediatric and neonatal care.
  • Potential for value-based care initiatives.

Threats

  • Increasing regulatory scrutiny and compliance burdens.
  • Physician burnout and potential for independent practice movements.
  • Economic downturns impacting healthcare spending.
  • Cybersecurity risks and data privacy concerns.
  • Consolidation among hospital systems leading to fewer but larger contracting partners.

Competitors and Market Share

Key competitor logo Key Competitors

  • Envision Healthcare Corporation (EVHC - no longer publicly traded)
  • TeamHealth Holdings, Inc. (TH - no longer publicly traded)
  • US Acute Care Solutions, LLC
  • American Physician Partners
  • Sound Physicians

Competitive Landscape

Mednax faces a highly competitive landscape from both large, established national providers and smaller regional players. Its advantages lie in its scale, broad service offering, and established hospital relationships. However, competitors often compete on price, service customization, and physician recruitment/retention strategies. The trend of hospital consolidation can also shift bargaining power in favor of larger health systems.

Major Acquisitions

Various Physician Practices and Groups

  • Year: Ongoing
  • Acquisition Price (USD millions): Varies
  • Strategic Rationale: To expand service lines, geographic presence, and market share in key physician service areas. Acquisitions allow Mednax to quickly integrate new physician talent and hospital contracts.

Growth Trajectory and Initiatives

Historical Growth: Mednax has a history of growth driven primarily by acquisitions, expanding its service lines and geographic footprint. Organic growth has also contributed, though often at a slower pace. The company has periodically divested non-core assets to focus on its primary physician services businesses.

Future Projections: Future growth for Mednax is likely to be a combination of strategic acquisitions, organic expansion within existing service lines, and potentially the development of new service offerings. Analyst projections often consider market trends, regulatory changes, and the company's ability to integrate acquired businesses and retain key talent. Growth is expected in specialized areas like neonatology and pediatrics, as well as in anesthesia and radiology.

Recent Initiatives: Recent initiatives may include the divestiture of certain business segments to streamline operations, focus on core strengths, and improve profitability. The company might also be investing in technology to enhance service delivery and exploring new partnership models with healthcare systems.

Summary

Mednax, Inc. is a well-established physician services provider with a strong historical presence in pediatrics and neonatology. Its diversified service offerings across anesthesia and radiology present opportunities for continued growth. However, the company faces significant competition, regulatory pressures, and evolving healthcare reimbursement models. Its success hinges on its ability to manage physician networks efficiently, maintain strong hospital partnerships, and adapt to market changes.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Mednax Inc. Investor Relations
  • SEC Filings (10-K, 10-Q)
  • Financial News Outlets (e.g., Wall Street Journal, Bloomberg)
  • Industry Research Reports

Disclaimers:

This analysis is based on publicly available information and should not be considered financial advice. Market share data and competitor information are estimates and subject to change. Investors should conduct their own due diligence before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Mednax Inc

Exchange NYSE
Headquaters Sunrise, FL, United States
IPO Launch date 1995-09-19
CEO & Executive Chairman Mr. Mark S. Ordan
Sector Healthcare
Industry Medical Care Facilities
Full time employees 4120
Full time employees 4120

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in hospitals, pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.